Full Text View
Tabular View
No Study Results Posted
Related Studies
Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
This study is ongoing, but not recruiting participants.
Study NCT00002866   Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999   Last Updated: May 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Neutropenia
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Agranulocytosis
Breast Diseases
Hematologic Diseases
Leukocyte Disorders
Leukopenia
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
filgrastim
docetaxel
epirubicin hydrochloride
Additional drug interventions recognized in this trial
Epirubicin
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
NCIC Clinical Trials Group


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services